Role of Immuno-Oncology Drugs in Osteosarcoma Treatment

Irena Boulytcheva

doi:10.4172/2472-016X.1000177

ISSN 2472-016X

Journal of Orthopedic Oncology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mini Review
J Orthop Oncol 2022, Vol 8(4): 177
DOI: 10.4172/2472-016X.1000177

Role of Immuno-Oncology Drugs in Osteosarcoma Treatment

Irena Boulytcheva^*: Department of Medicine, Blokhin Russian Cancer Research Center, Russia

^*Corresponding Author : Irena Boulytcheva, Department of Medicine, Blokhin Russian Cancer Research Center, Russia, Email: irena@gmail.com

Received Date: Jul 01, 2022 / Published Date: Jul 30, 2022

View PDF Download PDF

Citation: Boulytcheva I (2022) Role of Immuno-Oncology Drugs in Osteosarcoma Treatment. J Orthop Oncol 8: 177. Doi: 10.4172/2472-016X.1000177

Copyright: © 2022 Boulytcheva I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.